New FDA Guidance on Orphan Drug Development

Monday, August 17, 2015

Source: RAPS

The US Food and Drug Administration (FDA) has released a draft guidance intended to help drugmakers tackle common issues encountered in the development of drugs to treat rare diseases.

View All News »